Association of Impaired Fasting Glucose With Cardiovascular Disease in the Absence of Risk Factor

被引:10
|
作者
Zuo, Yingting [1 ,2 ,3 ,4 ]
Han, Xinsheng [5 ]
Tian, Xue [1 ,2 ,3 ,4 ]
Chen, Shuohua [6 ]
Wu, Shouling [6 ]
Wang, Anxin [1 ,2 ]
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, China Natl Clin Res Ctr Neurol Dis, 119 South 4th Ring West Rd, Beijing 100070, Peoples R China
[2] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China
[3] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China
[4] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China
[5] Kai Feng Cent Hosp, Dept Neurol, Kaifeng, Peoples R China
[6] North China Univ Sci & Technol, Kailuan Hosp, Dept Cardiol, 57 Xinhua East Rd, Tangshan 063000, Peoples R China
来源
关键词
fasting plasma glucose; impaired fasting glucose; traditional ASCVD risk factors; cardiovascular disease; DIABETES-MELLITUS; SUBCLINICAL ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION; PLASMA-GLUCOSE; BLOOD-PRESSURE; HYPERTENSION; PREVALENCE; METAANALYSIS; EVENTS; HEALTH;
D O I
10.1210/clinem/dgab809
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The association between impaired fasting glucose and cardiovascular disease (CVD) in participants without atherosclerotic CVD (ASCVD) risk factors based on current definitions is unclear. The study aimed to examine the association of fasting glucose levels with CVD and its subtypes in persons without ASCVD risk factors. Methods This study included 38 297 participants [men 62.1%; mean age 47.9 (12.9) years] who were free of a history of CVD and absent of ASCVD risk factors and had a fasting plasma glucose (FPG) level between 70 to 125 mg/dL at baseline from Kailuan Study during 2006 and 2007. Participants were followed until new-onset CVD event, death, or December 31, 2017. Cox proportional hazards models were performed to evaluate the associations. Results During a median follow-up of 11.0 years (interquartile range 10.7-11.2 years), we observed 1217 incident CVD events. Compared with participants with FPG 70 to 99 mg/dL, the multivariable adjusted hazard ratios for CVD among participants with FPG 100 to 109 mg/dL and 110 to 125 mg/dL were 1.18 (95% CI 1.02-1.38) and 1.27 (95% CI 1.03-1.55), respectively. Multivariable-adjusted spline regression model showed a J-shaped association between FPG and the risk of CVD. Conclusions We found that among individuals without diabetes or other traditional ASCVD risk factors, there is an increased risk of incident CVD with increasing abnormal FPG levels. These results highlight the importance of primordial prevention for FPG level increases along with other traditional ASCVD risk factors.
引用
收藏
页码:E1710 / E1718
页数:9
相关论文
共 50 条
  • [21] Mean platelet volume as a marker of future cardiovascular disease risk in pregnant women with impaired fasting glucose and impaired glucose tolerance
    Kosus, Nermin
    Kosus, Aydin
    Turhan, Nilgun
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2012, 42 (02) : 245 - 251
  • [22] Lowering the threshold for impaired fasting glucose: Impact on disease prevalence and associated risk of diabetes and cardiovascular disease
    Vaccaro, O
    Di Bonito, P
    Masulli, M
    Galasso, R
    Riccardi, G
    DIABETES, 2005, 54 : A261 - A261
  • [23] Impaired Fasting Glucose and Risk of Cardiovascular Disease in Korean Men and Women The Korean Heart Study
    Kim, Hong-Kyu
    Kim, Chul-Hee
    Kim, Eun Hee
    Bae, Sung Jin
    Choe, Jaewon
    Park, Joong-Yeol
    Park, Seong-Wook
    Yun, Young Duk
    Baek, Soo-Jin
    Mok, Yejin
    Jee, Sun Ha
    DIABETES CARE, 2013, 36 (02) : 328 - 335
  • [24] Impaired glucose tolerance, but not impaired fasting glucose, is a risk factor for early-stage atherosclerosis
    Ando, T.
    Okada, S.
    Niijima, Y.
    Hashimoto, K.
    Shimizu, H.
    Tsuchiya, T.
    Yamada, M.
    Ohshima, K.
    Mori, M.
    Ono, K.
    DIABETIC MEDICINE, 2010, 27 (12) : 1430 - 1435
  • [25] Impaired glucose tolerance and impaired fasting glucose have different associated risk factor profiles
    Yusoff, K
    JOURNAL OF HYPERTENSION, 2004, 22 : S50 - S50
  • [26] Impaired Glucose Tolerance, Impaired Fasting Glucose and Cardiovascular Risk Factores in Euthyroid Patients with Autoimmune Thyroiditis
    Neves, Celestino
    Alves, Marta
    Pereira, Luis Miguel
    Ramalho, Renata
    Pimentel, Isolina
    Carvalho, Ema
    Carvalho, Davide
    Guimaraes, Cristina
    Ramos, Joao P.
    Palmares, Carmo
    Del-Gado, Jose Luis
    Medina, Jose Luis
    DIABETES, 2009, 58 : A571 - A572
  • [27] Impaired Fasting Glucose and the Risk of Incident Diabetes Mellitus and Cardiovascular Events
    Chatterjee, Saurav
    Maitra, Subhankar
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (24) : 2546 - 2547
  • [28] Frequency of Exposure to Impaired Fasting Glucose and Risk of Mortality and Cardiovascular Outcomes
    Lee, Seung-Hwan
    Han, Kyungdo
    Kwon, Hyuk-Sang
    Kim, Mee Kyoung
    ENDOCRINOLOGY AND METABOLISM, 2021, 36 (05) : 1007 - 1015
  • [29] Impaired glucose tolerance: a risk factor for type 2 diabetes and cardiovascular disease
    Chiasson, JL
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1998, 40 : S1 - S2
  • [30] Cardiovascular prevention in subjects with impaired fasting glucose or impaired glucose tolerance
    Volpe M.
    Borghi C.
    Cavallo Perin P.
    Chiariello M.
    Manzato E.
    Miccoli R.
    Modena M.G.
    Riccardi G.
    Sesti G.
    Tiengo A.
    Trimarco B.
    Vanuzzo D.
    Verdecchia P.
    Zaninelli A.
    Del Prato S.
    High Blood Pressure & Cardiovascular Prevention, 2010, 17 (2) : 73 - 102